Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

Akkaya C., Kirli S., EKER S. S., Cangur S., Canbazoglu M., Sarandol A.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.20, no.4, pp.274-287, 2010 (SCI-Expanded) identifier identifier


Objective: This paper aims to compare the efficacy and safety of three widely used antidepressants, sertraline, reboxetine, a sertraline-reboxetine combination and venlafaxine, in the treatment of MDD and their effect on depressive symptoms in MDD patients.